Quartet closes an upsized A round with a novel approach to pain
MGH spinout and PIF portfolio company, Quartet Medicine, added $6.25 million to its Series A fundraise, closing the round at $23.25 million as it moves toward clinical trials with a newfangled way of treating chronic pain.
Printed from https://innovationblog.partners.org/quartet-closes-an-upsized-a-round-with-a-novel-approach-to-pain · Published 06 Nov 2018
© PARTNERS HEALTHCARE. ALL RIGHTS RESERVED